Amicus Therapeutics (FOLD) Depreciation & Amortization (IS) (2018 - 2025)
Historic Depreciation & Amortization (IS) for Amicus Therapeutics (FOLD) over the last 14 years, with Q3 2025 value amounting to $1.9 million.
- Amicus Therapeutics' Depreciation & Amortization (IS) fell 1364.06% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year decrease of 1247.7%. This contributed to the annual value of $8.5 million for FY2024, which is 856.09% up from last year.
- Amicus Therapeutics' Depreciation & Amortization (IS) amounted to $1.9 million in Q3 2025, which was down 1364.06% from $1.9 million recorded in Q2 2025.
- Amicus Therapeutics' 5-year Depreciation & Amortization (IS) high stood at $2.2 million for Q3 2023, and its period low was $1.3 million during Q1 2023.
- In the last 5 years, Amicus Therapeutics' Depreciation & Amortization (IS) had a median value of $1.8 million in 2025 and averaged $1.8 million.
- In the last 5 years, Amicus Therapeutics' Depreciation & Amortization (IS) plummeted by 4040.05% in 2021 and then skyrocketed by 7325.04% in 2023.
- Quarter analysis of 5 years shows Amicus Therapeutics' Depreciation & Amortization (IS) stood at $1.5 million in 2021, then dropped by 13.64% to $1.3 million in 2022, then skyrocketed by 66.44% to $2.2 million in 2023, then decreased by 6.46% to $2.0 million in 2024, then dropped by 8.18% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $1.9 million for Q2 2025, and $1.8 million during Q1 2025.